In the current study, we identified 24 differentially expressed lncRNAs in NPC including GAS5 [37, 38], NEAT1 [39, 40] and H19 [41-44], which contribute to the development and progression of cancers and might serve as novel, non-invasive biomarkers for cancer diagnosis, progression and prognosis. This evidence concerns the gene NEAT1 and nasopharyngeal carcinoma.